Finance

Lists
Q2 2027 earnings • in 5 days
See details
2M6:ETR
Medtronic PLC
€91.48
-0.28%
(-0.26) 1D
Nov 19, 5:35:50 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 2M6...
Open
€92.00
High
€92.00
Low
€90.52
Mkt. cap
128.70B
Avg. vol.
1.84K
Volume
3.49K
52-wk high
€94.94
52-wk low
€62.86
No. of employees
95K
Open
€92.00
High
€92.00
Low
€90.52
Mkt. cap
128.70B
Avg. vol.
1.84K
Volume
3.49K
52-wk high
€94.94
52-wk low
€62.86
No. of employees
95K
News stories
From web sources and news partners
Profile
Medtronic plc is an international medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue. The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter-defibrillator, and remote patient monitoring systems. They also created miniaturized devices like the world's smallest pacemaker and spinal cord stimulator. Wikipedia
About Medtronic PLC
CEOGeoffrey S. Martha
Employees95K
Founded1949
Headquarters-
SectorHealth Care
IndustryMedical device
Next call in 5 days
Tue, Nov 24, 2:30 PM
Fiscal period
Q2 2027
- / $1.33
Revenue / Est. (USD)
- / 9.48B
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
8.96B
9.02B
9.81B
9.76B
Cost of goods sold
3.06B
3.17B
3.40B
3.41B
Cost of revenue
3.06B
3.17B
3.40B
3.41B
Research and development expenses
754.00M
722.00M
671.00M
771.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.94B
2.93B
3.04B
3.17B
Operating expense
4.08B
4.04B
4.25B
4.48B
Total operating expenses
7.14B
7.21B
7.64B
7.89B
Operating income
1.82B
1.80B
2.16B
1.87B
Other non operating income
3.00M
13.00M
154.00M
33.00M
EBT including unusual items
1.60B
1.40B
1.84B
1.77B
EBT excluding unusual items
1.68B
1.66B
2.16B
1.82B
Income tax expense
215.00M
254.00M
575.00M
289.00M
Effective tax rate
13.47%
18.10%
31.34%
16.35%
Other operating expenses
-29.00M
-79.00M
126.00M
133.00M
Net income
1.37B
1.14B
1.24B
1.47B
Net profit margin
15.33%
12.68%
12.68%
15.07%
Earnings per share
1.36
1.36
1.55
1.45
Interest and investment income
89.00M
102.00M
73.00M
102.00M
Interest expense
-181.00M
-181.00M
-176.00M
-186.00M
Net interest expenses
-92.00M
-79.00M
-103.00M
-84.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.52B
2.52B
2.88B
2.60B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps